ALSP Inc. (American Life Science Pharmaceuticals, Inc.), is a privately held
company based in San Diego, California, developing small molecule drugs for treating neurodegenerative diseases, initially focused on Alzheimer's disease. Our approach is to identify key enzymes in the brain, called neuroproteases that produce biologically active peptides that are thought to cause the disease. We then use those enzymes as targets for screening compounds that inhibit the neuroproteases and thereby reduce production of the harmful peptides to treat the disease.
By using this innovative process, we have identified a family of drugs that is highly effective at reversing the symptoms of Alzheimer's in animal models of the disease. We are advancing our lead compound into clinical trials and continuing our search for additional drugs to treat Alzheimer’s and other devastating neurodegenerative diseases.
